Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service. Population Cohort [MedeA21].

NCT06607445 is registered in ClinicalTrials.gov with Complejo Hospitalario Universitario de Badajoz as lead sponsor.

NCT NCT06607445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06607445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service. Population Cohort [MedeA21].
Lead sponsor
Complejo Hospitalario Universitario de Badajoz
Phase
Observational
Overall status
Recruiting
Start date
May 26, 2021
Completion date
December 31, 2024
Enrollment
6,445 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug event